134 related articles for article (PubMed ID: 30697230)
1. Regulatory Network and Prognostic Effect Investigation of PIP4K2A in Leukemia and Solid Cancers.
Zhang S; Li Z; Yan X; Bao L; Deng Y; Zeng F; Wang P; Zhu J; Yin D; Liao F; Zhou X; Zhang D; Xia X; Wang H; Yang X; Zhang W; Gao H; Zhang W; Yang L; Hou Q; Xu H; Zhang Y; Shu Y; Wang Y
Front Genet; 2018; 9():721. PubMed ID: 30697230
[TBL] [Abstract][Full Text] [Related]
2. Association Between PIP4K2A Polymorphisms and Acute Lymphoblastic Leukemia Susceptibility.
Liao F; Yin D; Zhang Y; Hou Q; Zheng Z; Yang L; Shu Y; Xu H; Li Y
Medicine (Baltimore); 2016 May; 95(18):e3542. PubMed ID: 27149463
[TBL] [Abstract][Full Text] [Related]
3. Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia.
Hou Q; Liao F; Zhang S; Zhang D; Zhang Y; Zhou X; Xia X; Ye Y; Yang H; Li Z; Wang L; Wang X; Ma Z; Zhu Y; Ouyang L; Wang Y; Zhang H; Yang L; Xu H; Shu Y
Oncotarget; 2017 May; 8(22):36040-36053. PubMed ID: 28415601
[TBL] [Abstract][Full Text] [Related]
4. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
Lima K; Coelho-Silva JL; Kinker GS; Pereira-Martins DA; Traina F; Fernandes PACM; Markus RP; Lucena-Araujo AR; Machado-Neto JA
Cancer Genet; 2019 Apr; 233-234():56-66. PubMed ID: 31109595
[TBL] [Abstract][Full Text] [Related]
5. Differential profile of PIP4K2A expression in hematological malignancies.
Lima K; Ribeiro DM; Campos Pde M; Costa FF; Traina F; Saad ST; Sonati Mde F; Machado-Neto JA
Blood Cells Mol Dis; 2015 Oct; 55(3):228-35. PubMed ID: 26227852
[TBL] [Abstract][Full Text] [Related]
6. Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia.
Liao F; Ye Y; Yin D; Qin Y; Zhao J; Zhang W; Zhang Y; Deng Z; Wang Y; Ying B; Wang L; Gao J; Shu Y; Zhu Y; Lu X
Front Genet; 2020; 11():1004. PubMed ID: 33193587
[TBL] [Abstract][Full Text] [Related]
7. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility in childhood acute lymphoblastic leukemia.
Gutierrez-Camino A; Martin-Guerrero I; García-Orad A
Med Oncol; 2017 Sep; 34(10):179. PubMed ID: 28905228
[TBL] [Abstract][Full Text] [Related]
9. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia.
Lima K; Nogueira FL; Cipelli M; Carvalho MFL; Pereira-Martins DA; da Silva WF; Cavaglieri RC; Nardinelli L; Leal AM; Velloso EDRP; Bendit I; Câmara NOS; Schuringa JJ; Machado-Neto JA; Rego EM
Eur J Pharmacol; 2024 Jun; 977():176723. PubMed ID: 38851560
[TBL] [Abstract][Full Text] [Related]
10. Molecular events in follicular thyroid tumors.
Kroll TG
Cancer Treat Res; 2004; 122():85-105. PubMed ID: 16209039
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
Chow YP; Alias H; Jamal R
BMC Cancer; 2017 Feb; 17(1):120. PubMed ID: 28183295
[TBL] [Abstract][Full Text] [Related]
12. Preferentially Expressed Antigen of Melanoma (PRAME) and Wilms' Tumor 1 (WT 1) Genes Expression in Childhood Acute Lymphoblastic Leukemia, Prognostic Role and Correlation with Survival.
Khateeb EE; Morgan D
Open Access Maced J Med Sci; 2015 Mar; 3(1):57-62. PubMed ID: 27275197
[TBL] [Abstract][Full Text] [Related]
13. Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.
Mousavian Z; Nowzari-Dalini A; Stam RW; Rahmatallah Y; Masoudi-Nejad A
Cell Oncol (Dordr); 2017 Feb; 40(1):33-45. PubMed ID: 27798768
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
15. Genetic susceptibility to childhood acute lymphoblastic leukemia.
Sinnett D; Krajinovic M; Labuda D
Leuk Lymphoma; 2000 Aug; 38(5-6):447-62. PubMed ID: 10953966
[TBL] [Abstract][Full Text] [Related]
16. Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia.
Busche S; Ge B; Vidal R; Spinella JF; Saillour V; Richer C; Healy J; Chen SH; Droit A; Sinnett D; Pastinen T
Cancer Res; 2013 Jul; 73(14):4323-36. PubMed ID: 23722552
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
18. Pediatric acute lymphoblastic leukemia.
Carroll WL; Bhojwani D; Min DJ; Raetz E; Relling M; Davies S; Downing JR; Willman CL; Reed JC
Hematology Am Soc Hematol Educ Program; 2003; ():102-31. PubMed ID: 14633779
[TBL] [Abstract][Full Text] [Related]
19. Identification of a TSPY co-expression network associated with DNA hypomethylation and tumor gene expression in somatic cancers.
Kido T; Lau YC
J Genet Genomics; 2016 Oct; 43(10):577-585. PubMed ID: 27771326
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
Xu Z; Zhang Q; Luh F; Jin B; Liu X
Oncol Lett; 2019 Feb; 17(2):1865-1876. PubMed ID: 30675249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
